research that involves human subjects must be reviewed
other committees as well as the IRB before the research
is conducted. Review by other committees usually
depends on what the research includes (for example,
if it uses radiation, gene therapy, includes veterans
as subjects, etc) and/or where the research is going
to be conducted. Review by other committees is mandated
by university or hospital policy, in part due to
the risk to subjects that must be evaluated by these
other groups with specialized expertise.
by each committee occurs INDEPENDENTLY of IRB review.
If HURRC, IBC, and/or the VAMC Subcommittee for
Clinical Investigation must review your project,
you should submit your project to the applicable
committees prior to IRB review in order TO PREVENT
DELAYS IN STARTING YOUR PROJECT! The IRB does not
forward copies of your submission to the other committees
- it is the researcher's responsibility to submit
the research to all of the appropriate committees.
Please be sure to familiarize yourself with their
you want to conduct your research with the CTSI (formerly GCRC)?
a variety of resources to researchers. For more information visit
the CTSI's web site at https://www.ctsi.ufl.edu/.
your project involve the research use of radiation
and/or radioactive materials?
Human Use of Radioisotopes and Radiation Committee
(HURRC) must review all projects that involve
the research of diagnostic x-rays, radioactive materials, or therapeutic radiation, as well
as all research submitted to WIRB (regardless
of whether it involves radiation). Even a standard
diagnostic test used more frequently than clinically
indicated would constitute research with radiation.
If HURRC review is required, you cannot begin
the project until you have both IRB and HURRC
approvals. If you have questions about HURRC review,
please contact Ms. Susan Standford at (352) 392-7359 or via
e-mail at email@example.com.
Mail should be sent to Box 118340. Additional
information can be obtained at: http://www.ehs.ufl.edu/Rad/
Does your project involve human
Institutional Biosafety Committee (IBC) must review
all projects that involve HUMAN GENE THERAPY.
A project that needs IBC review cannot begin until
it has the approval of both the IBC and the IRB.
Also, the IBC will review all revisions to human
gene therapy projects to ensure that National
Institutes of Health guidelines are being met.
Therefore, investigators will be required to SUBMIT
ALL REVISIONS TO BOTH the IBC and the IRB. If
you have questions about IBC review, please contact
Dr. Phillip S. Collis at 392-1591 or via e-mail
Mail should be sent to Box 112190. Additional
information can be obtained at: http://www.ehs.ufl.edu/Bio/default.asp
Will your project or part of
your project be conducted at the VAMC?
the IRB's website about conducting research at
the North Florida/South Georgia Veteran Health
the VA's new research web site at: